First, it was Ivermectin. Then, it was Hydroxychloroquine. Now they have come for the monoclonal antibodies. The U.S. Food and Drug Administration (FDA) announced Monday it was halting emergency-use authorizations (EUA) for two monoclonal antibody therapies, one made by Regeneron Pharmaceuticals and one by Eli Lilly, falsely claiming the treatments are not effective against the […]